Authority listing for RISPERIDONE (Risperdal) Last Updated: April 2005
Authority required Behavioural disturbances characterised by psychotic symptoms and aggression in patients with dementia where non-pharmacological methods have been unsuccessful. CAUTION: In placebo controlled trials in elderly patients with dementia there was a significantly higher incidence of cerebrovascular adverse events, such as stroke (including fatalities) and transient ischaemic attacks, in patients treated with risperidone compared with patients treated with placebo. Michael Horst Herb wrote: > On Thursday 15 February 2007 09:33, Cedric Meyerowitz wrote: >> Now, if all these Dr's who prescribed incorrectly on the PBS rectify >> matters and don't, then with the saving maybe Zyprexa may also be approved >> in Dementia. > > To my knowledge, Risperidone and Olanzapine cost roughly the same. > They also work roughly the same, and indications are unsurprisingly the same > > And I just now this very momemnt I checked the newest MIMS - Authority > restrictions are unsurprisingly the same. It just states "Schizophrenia". Am > I missing something here? > > Horst > _______________________________________________ > Gpcg_talk mailing list > [email protected] > http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk > > _______________________________________________ Gpcg_talk mailing list [email protected] http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk
